Heritage Trust CO Biomarin Pharmaceutical Inc Transaction History

Heritage Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$74.77 - $85.47 $387,906 - $443,418	-5,188 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$75.51 - $84.79 $76,340 - $85,722	-1,011 Reduced 16.31%	5,188 $433,000
Q1 2021 May 12, 2021	BUY	$74.73 - $90.69 $7,547 - $9,159	101 Added 1.66%	6,199 $468,000
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $72,246 - $89,749	995 Added 19.5%	6,098 $535,000
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $74,888 - $136,533	-1,042 Reduced 16.96%	5,103 $388,000
Q2 2020 Aug 04, 2020	BUY	$79.55 - $124.22 $488,834 - $763,331	6,145 New	6,145 $758,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Heritage Trust CO, based on Form 13F filings with the SEC.

Stay updated on Heritage Trust CO with notifications on news.